4HCV
Crystal structure of ITK in complex with compound 53
Summary for 4HCV
Entry DOI | 10.2210/pdb4hcv/pdb |
Related | 4HCT 4HCU |
Descriptor | Tyrosine-protein kinase ITK/TSK, 3-{4-amino-1-[(3S)-1-propanoylpiperidin-3-yl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-N-[4-(propan-2-yl)phenyl]benzamide (3 entities in total) |
Functional Keywords | kinase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (human) |
Cellular location | Cytoplasm: Q08881 |
Total number of polymer chains | 1 |
Total formula weight | 31160.62 |
Authors | Han, S.,Caspers, N. (deposition date: 2012-10-01, release date: 2012-11-14, Last modification date: 2024-03-06) |
Primary citation | Zapf, C.W.,Gerstenberger, B.S.,Xing, L.,Limburg, D.C.,Anderson, D.R.,Caspers, N.,Han, S.,Aulabaugh, A.,Kurumbail, R.,Shakya, S.,Li, X.,Spaulding, V.,Czerwinski, R.M.,Seth, N.,Medley, Q.G. Covalent inhibitors of interleukin-2 inducible T cell kinase (itk) with nanomolar potency in a whole-blood assay. J.Med.Chem., 55:10047-10063, 2012 Cited by PubMed: 23098091DOI: 10.1021/jm301190s PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.48 Å) |
Structure validation
Download full validation report